logo
ProjectEnded

Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

Epitranscriptomic modifications constitute specific marks in mRNA that regulate gene expression. Identification of epitranscriptomic modifications requires next generation sequencing analyses and specific validation, processes that are cumbersome and time consuming. Furthermore, while some modifications are straightforward to identify, as they cause specific base changes (like RNA editing), most a

Status
Closed
Sector
Chemical (Industrial), Manufacturing (Industrial)
Location
Germany
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.” is an infrastructure initiative in the Chemical (Industrial) sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Epitranscriptomic modifications constitute specific marks in mRNA that regulate gene expression. Identification of epitranscriptomic modifications requires next generation sequencing analyses and specific validation, processes that are cumbersome and time consuming. Furthermore, while some modifications are straightforward to identify, as they cause specific base changes (like RNA editing), most are only detectable either through chemical means (requiring large quantities of material) or by immunoprecipitation followed by sequencing. Of these techniques, immunoprecipitation requires far less material and can be used in any molecular biology laboratory, but depends exquisitely on the quality of the monoclonal antibodies that recognize the modification - their specificity, selectivity and sensitivity. Most anti-modification antibodies are generated using traditional methods for the production of monoclonals to small molecule haptens (e.g. conjugation to a large protein carrier and injection into animals together with an adjuvant). While these methods can generate anti-hapten responses with some specificity they are generally not very selective. We have developed a novel immunization platform that exquisitely focuses the antibody response to a hapten to generate high affinity monoclonals with a high degree of specificity. We propose to employ this approach to generate anti-inosine antibodies (for the detection of editing in disease contexts); anti-m6A antibodies (which would be benchmarked against the ones currently in use, validating our approach); and antipseudo-uridine antibodies (a tool that is lacking in the field and for which traditional approaches have completely failed). The generation of specific and selective antibodies to these three modifications, will open the way toward a better understanding of their intricate molecular roles in biological proceGenerating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Chemical (Industrial), Manufacturing (Industrial)

Article published date

2026-03-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project